首页> 外文期刊>Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research >Efficacy and safety of ascending methotrexate dose in combination with adalimumab: the randomised CONCERTO trial
【24h】

Efficacy and safety of ascending methotrexate dose in combination with adalimumab: the randomised CONCERTO trial

机译:甲氨蝶呤剂量加阿达木单抗联合治疗的有效性和安全性:CONCERTO随机试验

获取原文
获取原文并翻译 | 示例
       

摘要

Objective CONCERTO was a randomised, double-blind, parallel-armed study of methotrexate (MTX) in combination with adalimumab to assess whether an increasing trend of efficacy and decreased safety exists when increasing MTX dose in patients with early rheumatoid arthritis (RA).
机译:目的CONCERTO是甲氨蝶呤(MTX)与阿达木单抗联合的一项随机,双盲,平行研究,旨在评估早期类风湿关节炎(RA)患者在增加MTX剂量时是否存在疗效增加和安全性降低的趋势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号